143 related articles for article (PubMed ID: 20501760)
41. Genetic determinants of circulating insulin-like growth factor (IGF)-I, IGF binding protein (BP)-1, and IGFBP-3 levels in a multiethnic population.
Cheng I; DeLellis Henderson K; Haiman CA; Kolonel LN; Henderson BE; Freedman ML; Le Marchand L
J Clin Endocrinol Metab; 2007 Sep; 92(9):3660-6. PubMed ID: 17566087
[TBL] [Abstract][Full Text] [Related]
42. Plasma vitamin B6 and the risk of colorectal cancer and adenoma in women.
Wei EK; Giovannucci E; Selhub J; Fuchs CS; Hankinson SE; Ma J
J Natl Cancer Inst; 2005 May; 97(9):684-92. PubMed ID: 15870439
[TBL] [Abstract][Full Text] [Related]
43. Anthropometric correlates of insulin-like growth factor 1 (IGF-1) and IGF binding protein-3 (IGFBP-3) levels by race/ethnicity and gender.
Faupel-Badger JM; Berrigan D; Ballard-Barbash R; Potischman N
Ann Epidemiol; 2009 Dec; 19(12):841-9. PubMed ID: 19944347
[TBL] [Abstract][Full Text] [Related]
44. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study.
Stattin P; Bylund A; Rinaldi S; Biessy C; Déchaud H; Stenman UH; Egevad L; Riboli E; Hallmans G; Kaaks R
J Natl Cancer Inst; 2000 Dec; 92(23):1910-7. PubMed ID: 11106682
[TBL] [Abstract][Full Text] [Related]
45. Determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1-3 in premenopausal women: physical activity and anthropometry (Netherlands).
Voskuil DW; Bueno de Mesquita HB; Kaaks R; van Noord PA; Rinaldi S; Riboli E; Grobbee DE; Peeters PH
Cancer Causes Control; 2001 Dec; 12(10):951-8. PubMed ID: 11808715
[TBL] [Abstract][Full Text] [Related]
46. Circulating insulin-like growth factor II and colorectal adenomas.
Renehan AG; Painter JE; O'Halloran D; Atkin WS; Potten CS; O'Dwyer ST; Shalet SM
J Clin Endocrinol Metab; 2000 Sep; 85(9):3402-8. PubMed ID: 10999841
[TBL] [Abstract][Full Text] [Related]
47. Lifestyle determinants of serum insulin-like growth-factor-I (IGF-I), C-peptide and hormone binding protein levels in British women.
Allen NE; Appleby PN; Kaaks R; Rinaldi S; Davey GK; Key TJ
Cancer Causes Control; 2003 Feb; 14(1):65-74. PubMed ID: 12708727
[TBL] [Abstract][Full Text] [Related]
48. Insulin-like Growth Factor-1, IGF-binding Protein-3, C-peptide and Colorectal Cancer: a Case-control Study.
Pankaj J; Kumari JR; Kim W; Lee SA
Asian Pac J Cancer Prev; 2015; 16(9):3735-40. PubMed ID: 25987030
[TBL] [Abstract][Full Text] [Related]
49. Hyperinsulinemia, insulin resistance and colorectal adenomas: A meta-analysis.
Yoon YS; Keum N; Zhang X; Cho E; Giovannucci EL
Metabolism; 2015 Oct; 64(10):1324-33. PubMed ID: 26169471
[TBL] [Abstract][Full Text] [Related]
50. The relation between nutritional factors and insulin-like growth factor-I in premenopausal women of different ethnicity.
Maskarinec G; Takata Y; Kaaks R
Eur J Nutr; 2005 Mar; 44(2):105-13. PubMed ID: 15309428
[TBL] [Abstract][Full Text] [Related]
51. IGF-Binding Proteins, Adiponectin, and Survival in Metastatic Colorectal Cancer: Results From CALGB (Alliance)/SWOG 80405.
Guercio BJ; Zhang S; Ou FS; Venook AP; Niedzwiecki D; Lenz HJ; Innocenti F; Pollak MN; Nixon AB; Mullen BC; O'Neil BH; Shaw JE; Polite BN; Benson AB; Atkins JN; Goldberg RM; Brown JC; O'Reilly EM; Mayer RJ; Blanke CD; Fuchs CS; Meyerhardt JA
JNCI Cancer Spectr; 2021 Feb; 5(1):. PubMed ID: 33426464
[TBL] [Abstract][Full Text] [Related]
52. Insulin-like growth factor I (IGF-I), IGF-binding protein-3 and the risk of colorectal adenoma and cancer in the Nurses' Health Study.
Giovannucci E; Pollak M; Platz EA; Willett WC; Stampfer MJ; Majeed N; Colditz GA; Speizer FE; Hankinson SE
Growth Horm IGF Res; 2000 Apr; 10 Suppl A():S30-1. PubMed ID: 10984283
[No Abstract] [Full Text] [Related]
53. Prediagnostic plasma IGFBP-1, IGF-1 and risk of prostate cancer.
Cao Y; Nimptsch K; Shui IM; Platz EA; Wu K; Pollak MN; Kenfield SA; Stampfer MJ; Giovannucci EL
Int J Cancer; 2015 May; 136(10):2418-26. PubMed ID: 25348852
[TBL] [Abstract][Full Text] [Related]
54. Maternal plasma concentrations of IGF-1, IGFBP-1, and C-peptide in early pregnancy and subsequent risk of gestational diabetes mellitus.
Qiu C; Vadachkoria S; Meryman L; Frederick IO; Williams MA
Am J Obstet Gynecol; 2005 Nov; 193(5):1691-7. PubMed ID: 16260212
[TBL] [Abstract][Full Text] [Related]
55. Ethnic disparity in the relationship between obesity and plasma insulin-like growth factors: the multiethnic cohort.
Henderson KD; Goran MI; Kolonel LN; Henderson BE; Le Marchand L
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2298-302. PubMed ID: 17119061
[TBL] [Abstract][Full Text] [Related]
56. Growth promoting peptides in diabetic and non-diabetic pregnancy: interactions with trophoblastic receptors and serum carrier proteins.
Culler FL; Tung RF; Jansons RA; Mosier HD
J Pediatr Endocrinol Metab; 1996; 9(1):21-9. PubMed ID: 8887130
[TBL] [Abstract][Full Text] [Related]
57. Insulin-like growth factor-I and binding protein-3 and risk of cancer.
Giovannucci E
Horm Res; 1999; 51 Suppl 3():34-41. PubMed ID: 10592442
[TBL] [Abstract][Full Text] [Related]
58. Re: Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.
Renehan AG; O'Dwyer ST; Shalet SM
J Natl Cancer Inst; 1999 Dec; 91(23):2051-2. PubMed ID: 10580038
[No Abstract] [Full Text] [Related]
59. Metformin therapy increases insulin-like growth factor binding protein-1 in hyperinsulinemic women with polycystic ovary syndrome.
Pawelczyk L; Spaczynski RZ; Banaszewska B; Duleba AJ
Eur J Obstet Gynecol Reprod Biol; 2004 Apr; 113(2):209-13. PubMed ID: 15063962
[TBL] [Abstract][Full Text] [Related]
60. Increase in circulating levels of IGF-1 and IGF-1/IGFBP-3 molar ratio over a decade is associated with colorectal adenomatous polyps.
Soubry A; Il'yasova D; Sedjo R; Wang F; Byers T; Rosen C; Yashin A; Ukraintseva S; Haffner S; D'Agostino R
Int J Cancer; 2012 Jul; 131(2):512-7. PubMed ID: 21898383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
